Literature DB >> 24100663

[Cicatricial alopecias].

R M Trüeb1.   

Abstract

Cicatricial alopecias are a diagnostic and therapeutic challenge. The irreversibility and cosmetic sequelae of cicatricial alopecia demand special diagnostic attention. Loss of follicular orifices points to permanent hair loss, due to irreversible damage to essential parts of the follicle or destruction of the entire follicle. Where there is no obvious physical/chemical injury or acute infectious etiology, clinical differential diagnosis may be difficult. Clinical inspection is of limited usefulness. Accurate diagnosis based on a careful patient history, examination, microbiological studies, and scalp biopsy are prerequisite to therapy. On the basis of histology, a differentiation is made between primary cicatricial alopecias due to preferential destruction of the follicle, and secondary cicatricial alopecias resulting from events outside impinging upon and eradicating the follicle. The primary cicatricial alopecias include well-defined chronic inflammatory diseases differentiated depending on the type and pattern of inflammation. Although clinicopathologic features allow for diagnosis in most cases, therapeutic limits reflect the boundaries of our present understanding. With expanding technologies for dissecting the immunologic and molecular basis, there is hope for a deeper understanding of the underlying pathogenesis and novel therapeutic interventions.

Entities:  

Mesh:

Year:  2013        PMID: 24100663     DOI: 10.1007/s00105-013-2577-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  29 in total

1.  Erosive pustular dermatosis of the scalp following radiation therapy for solar keratoses.

Authors:  R M Trüeb; M Krasovec
Journal:  Br J Dermatol       Date:  1999-10       Impact factor: 9.302

2.  Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus.

Authors:  Emmanuel Laffitte; Gürkan Kaya; Vincent Piguet; Jean-Hilaire Saurat
Journal:  Arch Dermatol       Date:  2003-06

3.  First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans.

Authors:  B Matard; T Meylheuc; R Briandet; I Casin; P Assouly; B Cavelier-balloy; P Reygagne
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-07-11       Impact factor: 6.166

Review 4.  [Scar forming alopecia. Comments on classification, differential diagnosis and pathobiology].

Authors:  B Hermes; R Paus
Journal:  Hautarzt       Date:  1998-06       Impact factor: 0.751

5.  Medical and environmental risk factors for the development of central centrifugal cicatricial alopecia: a population study.

Authors:  Angela Kyei; Wilma Fowler Bergfeld; Melissa Piliang; Pamela Summers
Journal:  Arch Dermatol       Date:  2011-04-11

6.  Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.

Authors:  L Weibel; M C Sampaio; M T Visentin; K J Howell; P Woo; J I Harper
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

7.  Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern?

Authors:  M S Zinkernagel; R M Trüeb
Journal:  Arch Dermatol       Date:  2000-02

8.  Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.

Authors:  S Kossard; M S Lee; B Wilkinson
Journal:  J Am Acad Dermatol       Date:  1997-01       Impact factor: 11.527

Review 9.  Hair and nail involvement in lupus erythematosus.

Authors:  Ralph M Trüeb
Journal:  Clin Dermatol       Date:  2004 Mar-Apr       Impact factor: 3.541

10.  [Lichen planopilaris simulating postmenopausal frontal fibrosing alopecia (Kossard)].

Authors:  R M Trüeb; R Torricelli
Journal:  Hautarzt       Date:  1998-05       Impact factor: 0.751

View more
  2 in total

Review 1.  The Diagnosis and Treatment of Hair and Scalp Diseases.

Authors:  Hans Wolff; Tobias W Fischer; Ulrike Blume-Peytavi
Journal:  Dtsch Arztebl Int       Date:  2016-05-27       Impact factor: 5.594

2.  [Drug treatment of alopecia].

Authors:  H Wolff
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.